Intrinsic Resistance to Colistin in the Genus Hafnia
Journal of Clinical Microbiology · 23.05.2023 · 61 (5)
DOI: 10.1128/jcm.01326-22 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Microbiology, erschienen am 23.05.2023. Verfasst von Sarah E Turbett und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Massachusetts General Hospital, Boston, Massachusetts, USA. Hauptthemen laut MEDLINE: Hafnia, Anti-Infective Agents. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCEZID CDC HHS, NIAID NIH HHS, ACL HHS.
Abstract (Originalsprache)
A bacterial species is considered to be intrinsically resistant to an antimicrobial when nearly all of the wild-type isolates (i.e., those without acquired resistance) exhibit minimum inhibitory concentration (MIC) values that are sufficiently high such that susceptibility testing is unnecessary, and that the antimicrobial should not be considered for therapy. Accordingly, knowledge of intrinsic resistance influences both the selection of treatment regimens and the approach to susceptibility testing in the clinical laboratory, where unexpected results also facilitate the recognition of microbial identification or susceptibility testing errors.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathology, Massachusetts General Hospital, Boston, Massachusetts, USA.
- Division of Infectious Diseases, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA.
- Harvard Medical School, Department of Medicine, Boston, Massachusetts, USA.
- Harvard Medical School, Department of Pathology, Boston, Massachusetts, USA.
- Infectious Disease and Microbiome Program, Broad Institute of MIT and Harvard, Boston, Massachusetts, USA.
- Pediatric Infectious Disease Unit, MassGeneral Hospital for Children, Boston, Massachusetts, USA.
ORCID-Profile: Sarah E Turbett, Virginia M Pierce
Förderung
- NCEZID CDC HHS
- NIAID NIH HHS
- ACL HHS
- Vickery-Colvin Grant Fund at the Massachusetts General Hospital
- HHS | NIH | National Institute of Allergy and Infectious Diseases
- HHS | Centers for Disease Control and Prevention
Zitieren
APA
Turbett, S. E., Bronson, R. A., Worby, C. J., McGrath, G. E. G., Hodgkins, E., Becker, M., Belford, B., Kogut, L., Oliver, E., Ryan, E. T., LaRocque, R. C., Earl, A. M., & Pierce, V. M. (2023). Intrinsic Resistance to Colistin in the Genus Hafnia. Journal of Clinical Microbiology, 61(5). https://doi.org/10.1128/jcm.01326-22
Vancouver
Turbett SE, Bronson RA, Worby CJ, McGrath GEG, Hodgkins E, Becker M, et al. Intrinsic Resistance to Colistin in the Genus Hafnia. Journal of Clinical Microbiology. 2023;61(5). doi:10.1128/jcm.01326-22
BibTeX
@article{Turbett2023,
author = {Turbett, Sarah E and Bronson, Ryan A and Worby, Colin J and McGrath, Graham E G and Hodgkins, Emily and Becker, Margaret and Belford, Barbara and Kogut, Lucyna and Oliver, Elizabeth and Ryan, Edward T and LaRocque, Regina C and Earl, Ashlee M and Pierce, Virginia M},
title = {Intrinsic Resistance to Colistin in the Genus Hafnia},
journal = {Journal of Clinical Microbiology},
year = {2023},
volume = {61},
number = {5},
doi = {10.1128/jcm.01326-22}
}
EUVIMED